Biosensors and Nanotheranostics
Discover the perfect home for your research. Our extensive collection of journals and sections spans over thousands academic disciplines, ensuring you find the right fit for your work.
Explore trending research themes and collaborate with leading experts. Join an existing community or start a new one to advance knowledge in emerging areas...
Begin your publishing journey with confidence. Access our comprehensive author hub for expert guidance, tools, and resources to help you prepare, submit, and share your research effectively.
Ready to make an impact? Submit your work today and amplify its reach by publishing with us. Start your submission process quickly and easily.
Benefit from our efficient peer review system. Receive timely decisions on your manuscript—our average acceptance time is just 120 days.
Biosensors and Nanotheranostics
Biosensors and Nanotheranostics is an open-access, peer-reviewed international journal dedicated to advancing the fields of biosensors, nanomedicine, and associated technologies. Our mission is to offer a premier platform for the dissemination of original research and innovative applications acro
Editorial board
See all >
Volumes
See all (5) >Article
Biosensors and Nanotheranostics
Table of Contents
Research Article
Pharmaceuticals and Drug Delivery
Nanomaterials Targeting Red Blood Cells: Implications for Drug Delivery and Biosensing
Saba Niaz 1*, Guillaume Bastiat Partner 1
This study advances RBC-based nano-carriers using pseudopeptidic polymers and improved purification, enhancing targeted, personalized, and sustained drug delivery.
Abstract | Full Text |PDF (832 KB) | Open Access Article
Saba Niaz 1*, Guillaume Bastiat Partner 1
This study demonstrates peptide nucleic acid conjugates stabilizing RNA G-quadruplexes, offering a novel approach to oncogene translation regulation.
Abstract | Full Text |PDF (586 KB) | Open Access Article
Development of Peptide-Polymer Conjugates for Enhanced Cartilage Tissue Engineering
Oleg Kolosov 1*, Gordon Hamilton 1, Cheryl Hawkes 1
This study develops bioactive peptide-polymer scaffolds, enhancing chondrocyte proliferation, ECM deposition, and mechanical properties for advanced cartilage tissue engineering applications.
Abstract | Full Text |PDF (1 MB) | Open Access Article
Polymer-Based Systems for Targeted miRNA Delivery
Oleg Kolosov 1*
This study develops thermoresponsive star copolymers with potential for efficient, biocompatible nucleic acid delivery in biomedical applications.
Abstract | Full Text |PDF (646 KB) | Open Access Article
Mourtas Spyridon 1,2*
Graphene and MoS2 functionalized with copolymers offer enhanced biocompatibility and efficiency for targeted cancer treatment via photothermal therapy.
Abstract | Full Text |PDF (778 KB) | Open Access Article
Ikram Ullah Khan 1*
This study determined the silica-gold core-shell nanoparticles' synthesis and characterization, with their superior catalytic potential for environmental applications.
Abstract | Full Text |PDF (422 KB) | Open Access Article
Covalently Crosslinked Lipid Nanocapsule-Based Hydrogels Induces the Modern Drug Delivery Efficacy
Saba Niaz 1*, Guillaume Bastiat Partner 2, Patrick Saulnier 2
This study showed a novel covalently crosslinked hydrogel system, enhancing drug delivery via improved mechanical stability and controlled release.
Abstract | Full Text |PDF (402 KB) | Open Access Article
Saba Niaz 1, Sam Au 1*
This study developed optimized nanogels for precise, pH-responsive drug release, potentially reducing side effects and improving targeted delivery efficiency.
Abstract | Full Text |PDF (467 KB) | Open Access Article
Sam Au 1*
Continuous LbL nanocapsule production could revolutionize scalable drug delivery, enhancing targeted, efficient treatments through controlled release mechanisms.
Abstract | Full Text |PDF (1 MB) | Open Access Article
Inorganic Drug Release from Mesoporous Silica Nanoparticles for Cancer Treatment
Carla Caramella 1*
The study demonstrated that controlled synthesis of mesoporous silica nanoparticles enables efficient, targeted cancer treatment with reduced toxicity.
Abstract | Full Text |PDF (860 KB) | Open Access Article
Carla Caramella 1*
This study demonstrated the potential of Zn and Mg doped MSNs in targeted cancer therapy and bone metastasis prevention.
Abstract | Full Text |PDF (585 KB) | Open Access Article
Klepetsanis Pavlos 1*
This study showed that the tailoring of nano-templates' surface properties can optimize lysozyme crystallization, improving efficiency in protein purification and structural studies.
Abstract | Full Text |PDF (467 KB) | Open Access Article
Synthesis, Characterization and Biomedical Potential of Peptide-Gold Nanoparticle Hydrogels
Ikram Ullah Khan 1*
This study demonstrated multifunctional hybrid hydrogels with potential for biomedical applications, combining enhanced mechanical properties and tunable optical characteristics.
Abstract | Full Text |PDF (344 KB) | Open Access Article
Advancements in Hydrogel Applications for Mechanobiological Research and Mechanomedicine
Oleg Kolosov 1*
This study provides insights into optimizing photopolymerised MPC hydrogels for biomedical applications in mechanobiology and mechanomedicine, enhancing material design.
Abstract | Full Text |PDF (2 MB) | Open Access Article
Mourtas Spyridon 1*
This study determined nanoparticle synthesis via micelles for biofunctionalization, optimizing conditions for stable quantum dot arrays.
Abstract | Full Text |PDF (349 KB) | Open Access Article
Carla Caramella 1*
This study determines Zn-loaded mesoporous silica nanoparticles as a scalable, pH-responsive drug delivery system for cancer therapy.
Abstract | Full Text |PDF (659 KB) | Open Access Article
Klepetsanis Pavlos 1*
This research advances cancer drug delivery using mesoporous silica nanoparticles, offering precise, stimuli-responsive, and biocompatible therapeutic solutions.
Abstract | Full Text |PDF (486 KB) | Open Access Article
Antibacterial Efficacy and Proteomic Response of Silver Nanoparticles in Escherichia coli XL1-Red
Klepetsanis Pavlos 1*
This study determined AgNP antibacterial efficacy, resistance mechanisms in E. coli mutants, and impact of particle aggregation on nanoparticle performance.
Abstract | Full Text |PDF (355 KB) | Open Access Article
Ikram Ullah Khan 1*
This study showed cost-effective methods for synthesizing gold nanoparticles using polymeric micelles, enhancing their potential for biomedical applications.
Abstract | Full Text |PDF (1 MB) | Open Access Article
The peer-reviewed and edited version of record published online before inclusion in an issue
These articles have been peer reviewed and accepted for publication. They are still in production and have not been edited, so may differ from the final published form.
The Most Read ranking is based on the number of downloads in the last 60 days from papers published on the Biosensors and Nanotheranostics within the last 12 months. Usage statistics are updated daily.
-
Next-generation RNA medicine: antisense, siRNA, mRNA, and CRISPR systems with organ-targeted delivery
This study highlights RNA therapeutics’ transformative potential, bridging gene-level precision with clinical reality to redefine future personalized medicine.
-
Advancements in Biomaterial-Based Nucleic Acid Delivery Systems for In Situ Tissue Engineering: A Review
Combining biomaterial scaffolds with nucleic acid vectors enhances safety, delivery efficiency, and controlled release for regenerative medicine applications.
-
Iron Oxide Nanoparticles and Antioxidant Defense in Drought-Stressed Tomato: Mechanisms, Evidence, and Research Gaps
Dose-optimized iron oxide nanoparticles may reinforce tomato's antioxidant defenses, offering a promising, low-input route to drought resilience.
-
Electrochemical Sensing of Heavy Metals in Water for Field Deployment
Electrochemical heavy-metal sensors achieve trace-level sensitivity, but fouling, organic-matter binding and unvalidated algorithms still block dependable long-term field water monitoring.
-
Scalable Microfluidic Manufacturing of Theranostic Liposomes: Batch Consistency and GMP-Ready Process Design
Microfluidic continuous-flow manufacturing can turn theranostic liposomes from bespoke laboratory preparations into reproducible, scalable, GMP-ready products fit for clinical trials.
-
Patient-Derived Organoid Screening of Theranostic Nanoparticles to Address Tumour Heterogeneity in Colorectal Cancer
Organoid-based screening exposes nano–bio behaviour that two-dimensional culture hides, making theranostic nanomedicine selection patient-specific, heterogeneity-aware and clinically translatable.
-
Stealth Nanocarriers with a Tunable Protein Corona to Prolong Circulation and Reduce Hepatic Clearance in Cancer Nanotheranostics
Corona engineering converts nanocarrier surface chemistry into a controllable determinant of circulation time, hepatic escape and tumour delivery.
-
Closed-Loop Nanotheranostic Systems: Biosensor-Triggered Insulin Release from Glucose-Responsive Nanogels
Glucose-responsive nanogels can autonomously sense hyperglycemia and release insulin proportionally, offering a needle-sparing route toward hypoglycemia-free, self-regulated diabetes care.
-
Bridging the Translational Gap in Nanomedicine: From Biological Barriers to Regulatory Approval
This review explains why most nanomedicines fail clinically and outlines integrated biological, manufacturing and regulatory strategies to accelerate patient access.
-
Light-Directed Nanocrystal Growth: Plasmon-Driven Synthesis of Anisotropic Metal Nanostructures
Treating light as a programmable reagent lets chemists sculpt nanocrystal shape, size and handedness with spatial, spectral and temporal precision.
-
Promise and Pitfalls of Nanotechnology in Healthcare: Applications, Safety, and Ethical Considerations
Integrating clinical, toxicological, ethical, and regulatory evidence, this review shows nanomedicine's benefits depend on safety-by-design, harmonised regulation, and equitable access.
-
Single-Entity Electrochemistry for Ultrasensitive Molecular Diagnosis: Collision Dynamics, CRISPR Nanointerfaces, and Clinical Translation
Counting individual nanoparticle collisions, coupled with programmable CRISPR chemistry, could bring attomolar molecular diagnosis from specialist laboratories toward clinical use.
-
Engineering the Immune Interface of Targeted Nanocarriers: From Passive Stealth to Programmed Recognition
Reframing nanocarrier design around immune recognition—corona control, stealth beyond PEG, CD47 self-signalling, and transcytosis—enables rational, clinically translatable targeted delivery.
-
Next-Generation Nanomedicine: Emerging Technologies and the Future of Personalized Healthcare
Integrating smart nanocarriers, quantum sensing and digital twins could personalise therapy, but validation, manufacturing and regulation must mature first.
-
Plant-Derived Exosome-Like Nanovesicles as Natural Oral Drug Carriers for Inflammatory Bowel Disease: Biogenesis, Multi-Targeted Mechanisms, and Translational Prospects
Edible plant nanovesicles offer biocompatible, gut-stable, dual-acting oral carriers that target colonic inflammation while minimizing systemic toxicity in IBD.
-
Nanotechnology at the Frontier of Medicine: Applications in Diagnostics, Drug Delivery, Oncology, and Regenerative Therapy
Integrating diagnostic, therapeutic and regenerative nanotechnologies clarifies which platforms are clinically ready and which translational barriers demand coordinated, standardised research.
-
Nanotechnology-Driven Healthcare: Advances in Diagnosis, Therapy, and Disease Prevention
Smart nanomaterials unite sensing, targeted therapy and AI-guided monitoring, but standardized safety testing and scalable manufacture must precede clinical adoption.
-
Patient-Derived Organoid Screening of Theranostic Nanoparticles to Address Tumour Heterogeneity in Colorectal Cancer
Patient-derived organoids expose subclone-specific nanoparticle delivery that conventional models conceal, redirecting theranostic design toward the cells driving colorectal cancer relapse.
-
Inhalable Nanoparticle Theranostics for Targeted Delivery and Imaging in Multidrug-Resistant Tuberculosis
Inhalable nanotheranostics unite macrophage-targeted drug delivery, real-time lesion imaging, and host-directed immunity to confront multidrug-resistant tuberculosis beyond conventional antibiotics.
-
Salivary exosomal mRNA and biosensors for the non-invasive detection of oral cancer
Salivary exosomal mRNA, read by point-of-care biosensors, could move oral cancer detection from late biopsy to early, painless, repeatable screening
-
Ultrasound-activated nanoparticles for sonodynamic and immune therapy of liver cancer
Ultrasound-activated sonodynamic nanoparticles enable non-invasive, image-guided, immune-sensitizing destruction of deep-seated hepatocellular carcinoma beyond the reach of light.
-
Engineering nanoparticles for theranostics, gene delivery and precision medicine
Nanoscale carriers unify imaging, gene editing, and patient-specific targeting, converting fragmented preclinical promise into reproducible, scalable, clinically translatable precision therapeutics.
-
Scanning Electrochemical Microscopy in Biosensing and Cell Imaging: Principles, Hybrid Probe Architectures, and Emerging Bio-Interface Applications
Hybrid scanning electrochemical probes and antifouling bio-interfaces resolve living cellular chemistry locally, yet reproducible fabrication and clinical validation remain unresolved.Pages: 1-8
-
Long-Term Biodistribution, Biotransformation, and Safety of Fe3O4@Au Hybrid Nanoparticles: Implications for Clinical Translation in Theranostic Nanomedicine
Hybrid gold–iron oxide nanotheranostics show 12-month in vivo safety, iron-core biodegradation, and persistent but well-tolerated hepatosplenic gold retention.
-
Engineering Reproducible Theranostic Liposomes Through Continuous-Flow Microfluidics
Microfluidic continuous-flow manufacturing offers a reproducible, scalable, GMP-ready route to theranostic liposomes with precise, single-step control over critical quality attributes.
-
Immunomodulatory Nanovaccines with Built-In Imaging Tags for Tracking Lymph Node Delivery In Vivo
Built-in imaging tags turn lymph-node–targeted nanovaccines into trackable, see-and-correct theranostics that quantitatively link nodal delivery to downstream antitumor immunity.
-
Regulatory Pathways for Nanotheranostics and Nanobiosensors: A Comparative Review of FDA, EMA and Emerging-Market Frameworks
Harmonized, risk-proportionate regulation — not engineering alone — decides whether nanotheranostics and nanobiosensors reach patients equitably across high-income and emerging health systems.